Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
Liposomal bupivacaine has been explored for indications in regional anesthesia, but little has been reported about its use in pediatric patients. In March 2021, the FDA approved an indication for liposomal bupivacaine as an infiltrated local anesthetic in children older than the age of six. Despite...
Saved in:
Main Authors: | Gregory M. Halenda, Stylianos Voulgarelis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Anesthesiology |
Online Access: | http://dx.doi.org/10.1155/2021/8092204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Use of Liposomal Bupivacaine in Erector Spinae Plane Block for Pediatric Congenital Cardiac Surgery
by: Stylianos Voulgarelis, et al.
Published: (2021-01-01) -
Patient Complications after Interscalene Block: A Retrospective Comparison of Liposomal Bupivacaine to Nonliposomal Bupivacaine
by: Jacob L. Hutchins, et al.
Published: (2020-01-01) -
EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
by: Patrick Discepola, et al.
Published: (2020-01-01) -
Treatment of Digital Ischemia with Liposomal Bupivacaine
by: José Raul Soberón, et al.
Published: (2014-01-01) -
Preoperative Analgesia Efficacy of Liposomal Bupivacaine Following Pericapsular Nerve Group (PENG) Block in Patients with Hip Fracture: A Randomized Controlled Observer-Blinded Study
by: Haobin Peng, et al.
Published: (2024-12-01)